Sponsor
Checkpoint Therapeutics Inc.
95 Sawyer Road Suite 110, 02453-3471, United States
About the sponsor
Checkpoint Therapeutics Inc. focuses on cutaneous squamous cell carcinoma, with research activity centered on advanced disease that cannot be removed surgically or has spread beyond the skin.
- Unresectable cutaneous squamous cell carcinoma
- Metastatic cutaneous squamous cell carcinoma
- Advanced skin cancer
The sponsor’s clinical activity in this area reflects interest in treatment options for patients with limited local control and systemic disease involvement.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.